tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CPRX Stock Latest News

Catalyst Pharma Announces $200M Share Repurchase Program
Company AnnouncementsCatalyst Pharma Announces $200M Share Repurchase Program
29d ago
8K
CPRX
Nike reports Q1 beat, U.S. takes 5% stake in Lithium Americas: Morning Buzz
PremiumThe Fly
Nike reports Q1 beat, U.S. takes 5% stake in Lithium Americas: Morning Buzz
30d ago
F
AES
Catalyst Pharmaceuticals announces $200M share repurchase program
PremiumThe Fly
Catalyst Pharmaceuticals announces $200M share repurchase program
30d ago
CPRX
AI Analyst Is Bullish on These 3 “Strong Buy” Healthcare Stocks, 9/2/25
PremiumMarket News
AI Analyst Is Bullish on These 3 “Strong Buy” Healthcare Stocks, 9/2/25
2M ago
WST
BMRN
Catalyst Pharma Settles Patent Dispute with Lupin
PremiumCompany Announcements
Catalyst Pharma Settles Patent Dispute with Lupin
2M ago
8K
CPRX
Catalyst Pharmaceuticals announces settlement of FIRDAPSE patent litigation
PremiumThe FlyCatalyst Pharmaceuticals announces settlement of FIRDAPSE patent litigation
2M ago
CPRX
Catalyst Pharmaceuticals Reports Strong Q2 2025 Earnings
Premium
Company Announcements
Catalyst Pharmaceuticals Reports Strong Q2 2025 Earnings
3M ago
CPRX
Catalyst Pharmaceuticals Reports Strong Q2 2025 Earnings
Premium
Company Announcements
Catalyst Pharmaceuticals Reports Strong Q2 2025 Earnings
3M ago
CPRX
Catalyst Pharma Updates Guidelines for SCLC Treatment
PremiumCompany Announcements
Catalyst Pharma Updates Guidelines for SCLC Treatment
3M ago
8K
CPRX
Catalyst Pharmaceuticals reports Q2 EPS 68c, consensus 54c
PremiumThe Fly
Catalyst Pharmaceuticals reports Q2 EPS 68c, consensus 54c
3M ago
CPRX
Catalyst Pharma Reports Record Q2 2025 Financial Results
PremiumCompany Announcements
Catalyst Pharma Reports Record Q2 2025 Financial Results
3M ago
8K
CPRX
Catalyst announces NCCN Guidelines for SCLC include new additions
PremiumThe Fly
Catalyst announces NCCN Guidelines for SCLC include new additions
3M ago
CPRX
Catalyst Pharma Appoints Dr. Curran to Board
PremiumCompany AnnouncementsCatalyst Pharma Appoints Dr. Curran to Board
3M ago
8K
CPRX
Catalyst Pharmaceuticals appoints Curran to its board of directors
Premium
The Fly
Catalyst Pharmaceuticals appoints Curran to its board of directors
3M ago
CPRX
CPRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
CPRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
CPRX
Catalyst Pharmaceuticals CEO Daly buys 70,000 common shares
PremiumThe Fly
Catalyst Pharmaceuticals CEO Daly buys 70,000 common shares
5M ago
CPRX
Catalyst Pharma Appoints New Chief Medical Officer
PremiumCompany Announcements
Catalyst Pharma Appoints New Chief Medical Officer
5M ago
8K
CPRX
Catalyst Pharmaceuticals appoints William Andrews as CMO
PremiumThe Fly
Catalyst Pharmaceuticals appoints William Andrews as CMO
5M ago
CPRX
Catalyst Pharma Holds 2025 Annual Stockholders Meeting
PremiumCompany Announcements
Catalyst Pharma Holds 2025 Annual Stockholders Meeting
5M ago
8K
CPRX
Catalyst Pharma’s Strong Commercial Performance and Promising Revenue Guidance Justify Buy Rating
PremiumRatingsCatalyst Pharma’s Strong Commercial Performance and Promising Revenue Guidance Justify Buy Rating
6M ago
CPRX
Catalyst Pharma’s Strong Growth Prospects and Strategic Initiatives Drive Buy Rating
Premium
Ratings
Catalyst Pharma’s Strong Growth Prospects and Strategic Initiatives Drive Buy Rating
6M ago
CPRX
Catalyst Pharmaceuticals Reports Record Q1 2025 Results
Premium
Company Announcements
Catalyst Pharmaceuticals Reports Record Q1 2025 Results
6M ago
CPRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >